Qi Yi Luo
Direktor/Vorstandsmitglied bei MICROPORT SCIENTIFIC CORPORATION
Vermögen: 5 Mio $ am 30.04.2024
Aktive Positionen von Qi Yi Luo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MICROPORT SCIENTIFIC CORPORATION | Direktor/Vorstandsmitglied | 30.08.2023 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2003 | 30.08.2023 | |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Direktor/Vorstandsmitglied | 28.04.2020 | - |
Karriereverlauf von Qi Yi Luo
Ehemalige bekannte Positionen von Qi Yi Luo
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Direktor/Vorstandsmitglied | - | 15.09.2023 |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Direktor/Vorstandsmitglied | 05.08.2019 | 16.01.2020 |
Vorsitzender | 16.01.2020 | 29.08.2023 | |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Vorsitzender | 01.05.2015 | 29.08.2023 |
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Direktor/Vorstandsmitglied | 01.01.1991 | 01.01.1995 |
Ausbildung von Qi Yi Luo
Queen's University | Graduate Degree |
Yunnan Technology & Business University | Undergraduate Degree |
University of Shanghai for Science & Technology | Doctorate Degree |
Statistik
International
China | 7 |
Kanada | 3 |
Hong Kong | 2 |
Operativ
Director/Board Member | 5 |
Chairman | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
MICROPORT SCIENTIFIC CORPORATION | Health Technology |
SHANGHAI MICROPORT EP MEDTECH CO., LTD. | Commercial Services |
MICROPORT CARDIOFLOW MEDTECH CORPORATION | Health Technology |
Private Unternehmen | 3 |
---|---|
Vas-Cath, Inc.
Vas-Cath, Inc. Medical SpecialtiesHealth Technology Part of Becton, Dickinson & Co., Vas-Cath, Inc. is a Canadian company that specializes in catheters for hemodialysis. The private company is based in Mississauga, Canada. Vas-Cath was acquired by Bard Canada, Inc. on December 05, 1994. | Health Technology |
Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Shanghai MicroPort CardioFlow Medtech Co., Ltd. Medical SpecialtiesHealth Technology Part of MicroPort Scientific Corp., Shanghai MicroPort CardioFlow Medtech Co., Ltd. is a company headquartered in Shanghai, China. The firm designs, manufactures cardiac and orthopedic devices, functions as an investment holding & property management company. Jeffrey R. Lindstrom is the CEO, in this role since 2023. | Health Technology |
MicroPort Cardiac Rhythm Management International Ltd.
MicroPort Cardiac Rhythm Management International Ltd. Financial ConglomeratesFinance MicroPort Cardiac Rhythm Management International Ltd. operates as a commercial-stage medical technology company. It specializes in active implantable medical devices for cardiac rhythm management. The firm's product portfolio covers a CRM devices, including low-voltage CRM devices, namely, pacemakers (for abnormally slow heart rate, or bradycardia) and cardiac re-synchronization therapy pacemakers, high-voltage CRM devices, namely, implantable cardioverter defibrillators (ICD) and cardiac re-synchronization therapy defibrillators (CRT-D), CRM patient monitoring devices and arrhythmia diagnostic devices. The company was founded on September 10, 2019 and is headquartered in Hong Kong. | Finance |